Dr Elizabeth Hovey
Honorary Associate
NHMRC Clinical Trials Centre, Sydney Medical School
Telephone | +61 2 93822577 |
Fax | +61 2 9822588 |
|
Selected grants
2017
- Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma: the CODEL trial; Hovey E, Nowak A, Simes R, McDonald K, Drummond K, Buckland M, Koh E, Cher L; Cancer Council New South Wales/Research Project Grants.
- A 2:1 Randomised Phase II Study of NivolUmab and Temozolomide vs Temozolomide in Methylated newly diagnosed Elderly Glioblastoma (NUTMEG); Khasraw M, McDonald K, Rosenthal M, Ellingson B, Ashley D, Barnes E, Hovey E, Foote M, Yip S, Goh C; National Health and Medical Research Council (NHMRC)/Project Grants.
2013
- COGNO infrastructure funding for support, development and conduct of clinical trials and translational research; Hovey E, Simes R, Koh E, Agar M, McDonald K, Wheeler H; Cancer Institute NSW/Cooperative Clinical Trial (CCT) Grants.
Selected publications
|
|
|
|
|
|
|
|